Intuitive Surgical After-Hours Stock Movement: Insider Selling and Malaysia Expansion

Intuitive Surgical shares were a hot topic on Friday.

The California-based medical technology and robotics company's stock rose 0.14% to $375 in after-hours trading on Thursday.

In regular trading, ISRG closed at $374.48, down 5.84%.

Trading activity on Thursday was slightly above average, with 3.97 million shares changing hands versus an average volume of 3.7 million shares.

Intuitive Surgical is known for developing and manufacturing the da Vinci surgical system, an advanced robotic-assisted platform used to perform complex minimally invasive procedures.

Insider Selling

The stock movement stems from a Thursday filing with the U.S. Securities and Exchange Commission showing that Executive Vice President and Chief Manufacturing and Supply Chain Officer Mark Brosius sold 77 shares on Monday, Tuesday, and Wednesday each, at prices ranging from $390.67 to $394.26.

The three-day sell-off totaled 231 shares, valued at approximately $90,777.

These transactions were executed under a pre-arranged insider trading plan that expires on February 14, 2027.

Malaysia Expansion

The stock movement also stems from Intuitive Surgical's Monday announcement that it signed a lease agreement with the Penang Development Corporation to build a new 316,000-square-foot manufacturing facility in Penang, Malaysia.

The facility is expected to begin operations in 2028 and create 1,200 jobs by 2032, manufacturing surgical instruments and electromechanical equipment for the company's da Vinci surgical system.

Glenn Vavoso, Intuitive Surgical's Senior Vice President and President for the Asia-Pacific region, stated that "the Asia-Pacific region represents one of the most exciting growth opportunities for robotic-assisted surgery," adding that the move strengthens the company's ability to expand patient access in the region.

Trading Metrics and Technical Analysis

Intuitive Surgical has a market capitalization of $132.3 billion, with a 52-week high of $603.88 and a 52-week low of $328.57.

ISRG's relative strength index stands at 45.40.

The stock has declined 20.30% over the past 12 months.

ISRG is currently trading near the lower end of its 52-week range.

In August, Oppenheimer analyst Suraj Kalia upgraded the stock from Perform to Outperform, setting a $500 price target. Zacks Edge stock ranking indicates ISRG is experiencing a short-term uptrend while consolidating over the medium and long term.